| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytomx Therapeutics, Inc. (CTMX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CTMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.95M | - | |
| Other | 650.0K | $2.60M | - | |
| CFO | 78.3K | $312.6K | - | |
| Other | 43.8K | $174.8K | - | |
| Dir | 38.0K | $151.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | McCarthy Sean A.69 | CEO | Sell | 7,121 | $1.88 | $13,391.04 | -1.8% | -19.1% | +6.7% | |
| Mar 16, 2023 | Campoy Carlos | Chief Financial Officer | Sell | 1,748 | $1.98 | $3,459.47 | -4.4% | -19.1% | +6.7% | |
| Mar 16, 2023 | Rowland Lloyd A50 | General Counsel | Sell | 2,037 | $1.98 | $4,031.22 | -2.8% | -19.1% | +6.7% | |
| Mar 16, 2023 | Landau Jeffrey B55 | Chief Financial Officer | Sell | 1,477 | $1.98 | $2,923.28 | -2.1% | -19.1% | +6.7% | |
| Mar 16, 2023 | Peterson Amy C. | EVP, Chief Development Officer | Sell | 4,257 | $1.98 | $8,424.60 | -6.8% | -19.1% | +6.7% | |
| Jul 20, 2022 | Peterson Amy C. | EVP, Chief Development Officer | Sell | 7,463 | $1.42 | $10,612.39 | -10.6% | -6.6% | +18.5% | |
| Jul 20, 2022 | Landau Jeffrey B55 | Chief Business Officer | Sell | 4,206 | $1.42 | $5,981.77 | -12.0% | -6.6% | +18.5% | |
| Jul 20, 2022 | McCarthy Sean A.69 | President And CEO | Sell | 14,911 | $1.42 | $21,206.42 | -4.9% | -6.6% | +18.5% | |
| Jul 20, 2022 | Rowland Lloyd A50 | General Counsel | Sell | 5,602 | $1.42 | $7,967.72 | -11.4% | -6.6% | +18.5% | |
| Jul 20, 2022 | Hannah Alison L. | Chief Medical Officer | Sell | 5,602 | $1.42 | $7,965.48 | -14.9% | -6.6% | +18.5% |